In the commercial major medical health market, the significant difference between older and younger individuals becomes more important as our population gets older overall and as medical advances allow for longer lives (at a cost).  The Affordable Care Act implemented strict demographic rating restrictions on the individual and small group markets, but recent efforts have sought to relax these requirements.  What should insurers be ready to face in these already-challenging markets?